A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

P.M. Voorhees, R.F. Manges, P. Sonneveld, S. Jagannath, G. Somlo, A. Krishnan, S. Lentzsch, R.C. Frank, S. Zweegman, P.W. Wijermans, R.Z. Orlowski, B. Kranenburg, B. Hall, T. Casneuf, X. Qin, H. te Velde, H. Xie, S.K. Thomas

Research output: Contribution to journalArticleAcademicpeer-review

135 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)357-366
JournalBritish journal of haematology
Volume161
Issue number3
DOIs
Publication statusPublished - 2013

Cite this